Countouriotis Athena

CIK 00015714698 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001571469

Recent Transactions

50 trades

Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Deferred Restricted Stock Unit
2025-06-13+67,546→ 67,546 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (right to buy)
2025-05-28+201,857→ 201,857 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2025-05-20+6,650→ 13,550 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Deferred Restricted Stock Unit
2024-06-11+49,303→ 49,303 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-21+4,720→ 6,900 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (right to buy)
2024-05-21+47,693→ 47,693 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Deferred Restricted Stock Unit
2024-03-01+50,000→ 50,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-12-27+2,180→ 2,180 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Deferred Restricted Stock Unit
2023-06-06+51,955→ 51,955 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2023-05-25+24,000→ 24,000 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−155,844→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−67,575→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−325,000→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−224,640→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−173,389→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−989,971→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−101,775→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Common Stock
2022-08-17$76.00/sh−110,959→ 0 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Deferred Restricted Stock Unit
2022-06-10+51,204→ 51,204 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2022-05-26+24,000→ 24,000 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2022-02-09$36.30/sh−2,971→ 47,930 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-02-09+224,640→ 224,640 total
Award
Turning Point Therapeutics, Inc.
Common Stock
2022-02-09+62,400→ 110,330 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Stock Option (right to buy)
2021-06-29+35,000→ 35,000 total
Award
Passage BIO, Inc.$PASG
Director Stock Option (Right to Buy)
2021-05-27+16,918→ 16,918 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-11$138.55/sh−3,052→ 50,195 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-11$137.66/sh−1,571→ 53,247 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-11$136.45/sh−4,319→ 54,818 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Common Stock
2021-02-11$3.20/sh+8,942→ 59,137 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-11−8,942→ 173,389 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Common Stock
2021-02-10$3.20/sh+25,392→ 75,587 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-10$135.72/sh−5,227→ 69,335 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-10$134.34/sh−1,025→ 74,562 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-10$138.19/sh−433→ 50,195 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-10$137.46/sh−2,081→ 50,628 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-10$136.42/sh−16,626→ 52,709 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-10−25,392→ 182,331 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$3.20/sh+7,666→ 75,861 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$140.24/sh−1,104→ 50,195 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$3.20/sh+18,000→ 68,195 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$136.29/sh−6,200→ 69,661 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$137.58/sh−103→ 69,558 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$138.66/sh−4,969→ 64,589 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-09$139.69/sh−13,290→ 51,299 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-09−18,000→ 207,723 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-09−7,666→ 67,575 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-08+101,775→ 101,775 total
Award
Turning Point Therapeutics, Inc.
Common Stock
2021-02-08+22,617→ 50,195 total
Award
IOVANCE BIOTHERAPEUTICS, INC.$IOVA
Stock Option (right to buy)
2020-06-08+35,000→ 35,000 total
Purchase
Turning Point Therapeutics, Inc.
Common Stock
2020-05-21$60.00/sh+4,166→ 26,872 total

Companies

Recent Filings

Address

C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET

SAN DIEGO, CA, 92121

View on SEC.gov